NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 07 04:00PM ET
31.77
Dollar change
-0.32
Percentage change
-1.00
%
CategoryGlobal or ExUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y7.42% Total Holdings89 Perf Week-1.21%
SponsorGlobal X ETF Type Tagsequity Return% 3Y8.92% AUM58.39M Perf Month0.51%
Fund Family Bond Type Tagshealthcare Return% 5Y6.64% NAV/sh Perf Quarter3.55%
IndexIndxx Aging Population Thematic Index Average Maturity Tagspharmaceutical Return% 10Y 52W High33.64 -5.56% Perf Half Y5.23%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low27.43 15.84% Perf YTD5.23%
Active/Passive Quant Type Tags- Flows% 1M1.12% Volatility1.09% 0.87% Perf Year5.69%
Dividend TTM0.29 (0.91%) ESG Type Tags- Flows% 3M-1.96% ATR (14)0.40 Perf 3Y24.84%
Dividend Ex-DateJun 27, 2025 Dividend Type Sector/Theme Flows% YTD-4.01% RSI (14)51.47 Perf 5Y28.41%
Dividend Gr. 3/5Y6.32% 11.82% Structure Type Region Flows% 1Y Beta0.68 Perf 10Y-
Expense0.50% Growth/Value SMA20-0.24% Flows% 3Y Rel Volume1.40 Prev Close32.09
Inverse/Leveraged Market Cap SMA501.15% Flows% 5Y Avg Volume7.88K Price31.77
IPOMay 10, 2016 Option/ShortYes / No SMA2000.98% Trades Volume11,580 Change-1.00%
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-24-25 07:14AM
07:14AM
Apr-23-25 05:45AM
01:40PM Loading…
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Mar-19-25 03:52PM
Global X Aging Population ETF seeks results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index. The fund invests more than 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that facilitate the demographic trend of longer average life spans and the aging of the global population, including but not limited to companies involved in biotechnology, medical devices, pharmaceuticals, senior living facilities and specialized health care services.